These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 12651274)
1. Transferrin receptor-2 polymorphisms and iron overload in transfusion independent b-thalassemia intermedia. Ma ES; Lam KK; Chan AY; Ha SY; Au WY; Chan LC Haematologica; 2003 Mar; 88(3):345-6. PubMed ID: 12651274 [No Abstract] [Full Text] [Related]
2. Transferrin receptor 2 is a potential novel therapeutic target for β-thalassemia: evidence from a murine model. Artuso I; Lidonnici MR; Altamura S; Mandelli G; Pettinato M; Muckenthaler MU; Silvestri L; Ferrari G; Camaschella C; Nai A Blood; 2018 Nov; 132(21):2286-2297. PubMed ID: 30209118 [TBL] [Abstract][Full Text] [Related]
3. Soluble form of transferrin receptor-1 level is associated with the age at first diagnosis and the risk of therapeutic intervention and iron overloading in patients with non-transfusion-dependent thalassemia. Ricchi P; Meloni A; Costantini S; Spasiano A; Di Matola T; Pepe A; Cinque P; Filosa A Ann Hematol; 2017 Sep; 96(9):1541-1546. PubMed ID: 28707012 [TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassaemia major. Origa R; Satta S; Matta G; Galanello R Br J Haematol; 2008 Jul; 142(1):143-5. PubMed ID: 18477036 [No Abstract] [Full Text] [Related]
5. Non-transferrin-bound iron during blood transfusion cycles in beta-thalassemia major. Grosse R; Lund U; Caruso V; Fischer R; Janka GE; Magnano C; Engelhardt R; Dürken M; Nielsen P Ann N Y Acad Sci; 2005; 1054():429-32. PubMed ID: 16339692 [TBL] [Abstract][Full Text] [Related]
6. No evidence of cardiac iron in 20 never- or minimally-transfused patients with thalassemia intermedia. Origa R; Barella S; Argiolas GM; Bina P; Agus A; Galanello R Haematologica; 2008 Jul; 93(7):1095-6. PubMed ID: 18508795 [No Abstract] [Full Text] [Related]
7. Insight onto the pathophysiology and clinical complications of thalassemia intermedia. Cappellini MD; Musallam KM; Taher AT Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia. Musallam KM; Cappellini MD; Taher AT Blood Cells Mol Dis; 2013 Jun; 51(1):35-8. PubMed ID: 23425967 [TBL] [Abstract][Full Text] [Related]
9. Microarray analysis of liver gene expression in iron overloaded patients with sickle cell anemia and beta-thalassemia. Flanagan JM; Steward S; Hankins JS; Howard TM; Neale G; Ware RE Am J Hematol; 2009 Jun; 84(6):328-34. PubMed ID: 19384939 [TBL] [Abstract][Full Text] [Related]
11. Transferrin receptor 2 (Tfr2) genetic deletion makes transfusion-independent a murine model of transfusion-dependent β-thalassemia. Di Modica SM; Tanzi E; Olivari V; Lidonnici MR; Pettinato M; Pagani A; Tiboni F; Furiosi V; Silvestri L; Ferrari G; Rivella S; Nai A Am J Hematol; 2022 Oct; 97(10):1324-1336. PubMed ID: 36071579 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Association of Transferrin Receptor Type 2 Gene Mutation (Y250X) with Iron Overload in Major β- Thalassemia. Abdulmalek Jaafar J; Al-Rashedi NAM Arch Razi Inst; 2021 Nov; 76(5):1551-1554. PubMed ID: 35355750 [TBL] [Abstract][Full Text] [Related]
13. Decreased expression of membrane alpha4beta1, alpha5beta1 integrins and transferrin receptor on erythroblasts in splenectomized patients with beta-thalassemia intermedia. Parallel assessment of serum soluble transferrin receptors levels. Kossiva L; Paterakis G; Tassiopoulos S; Papadhimitriou SI; Voukouti E; Gligori I; Rombos Y Ann Hematol; 2003 Sep; 82(9):579-84. PubMed ID: 12904899 [TBL] [Abstract][Full Text] [Related]
14. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia. Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519 [TBL] [Abstract][Full Text] [Related]
15. Type 3 hemochromatosis and beta-thalassemia trait. Riva A; Mariani R; Bovo G; Pelucchi S; Arosio C; Salvioni A; Vergani A; Piperno A Eur J Haematol; 2004 May; 72(5):370-4. PubMed ID: 15059075 [TBL] [Abstract][Full Text] [Related]
16. Does aceruloplasminemia modulate iron phenotype in thalassemia intermedia? Pelucchi S; Pelloni I; Arosio C; Mariani R; Piperno A Blood Cells Mol Dis; 2016 Mar; 57():112-4. PubMed ID: 26777753 [No Abstract] [Full Text] [Related]
17. Commentary: mutations of transferrin receptor 2 (Trf-2) and iron storage disease. Beutler E Blood Cells Mol Dis; 2001; 27(1):294-5. PubMed ID: 11358391 [No Abstract] [Full Text] [Related]
18. Peroxidative stress and antioxidant enzymes in children with beta-thalassemia major. Naithani R; Chandra J; Bhattacharjee J; Verma P; Narayan S Pediatr Blood Cancer; 2006 Jun; 46(7):780-5. PubMed ID: 16317757 [TBL] [Abstract][Full Text] [Related]
19. Severe iron overload in Blackfan-Diamond anemia: a case-control study. Roggero S; Quarello P; Vinciguerra T; Longo F; Piga A; Ramenghi U Am J Hematol; 2009 Nov; 84(11):729-32. PubMed ID: 19810012 [TBL] [Abstract][Full Text] [Related]